The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2023 May 13

PMID 37174744

Authors

Xavier T R Moore

Lilia Gheghiani

Zheng Fu

Affiliations

Soon will be listed here.

Abstract

Polo-like kinase 1 (PLK1) is a serine/threonine kinase with more than 600 phosphorylation substrates through which it regulates many biological processes, including mitosis, apoptosis, metabolism, RNA processing, vesicle transport, and G DNA-damage checkpoint recovery, among others. Among the many PLK1 targets are members of the FOX family of transcription factors (FOX TFs), including FOXM1, FOXO1, FOXO3, and FOXK1. FOXM1 and FOXK1 have critical oncogenic roles in cancer through their antagonism of apoptotic signals and their promotion of cell proliferation, metastasis, angiogenesis, and therapeutic resistance. In contrast, FOXO1 and FOXO3 have been identified to have broad functions in maintaining cellular homeostasis. In this review, we discuss PLK1-mediated regulation of FOX TFs, highlighting the effects of PLK1 on the activity and stability of these proteins. In addition, we review the prognostic and clinical significance of these proteins in human cancers and, more importantly, the different approaches that have been used to disrupt PLK1 and FOX TF-mediated signaling networks. Furthermore, we discuss the therapeutic potential of targeting PLK1-regulated FOX TFs in human cancers.

Citing Articles

Discovery of a novel PLK1 inhibitor with high inhibitory potency using a combined virtual screening strategy.

Xu Z, Guan L, Wang Y, Niu M, Ruan Y, Xu C J Enzyme Inhib Med Chem. 2025; 40(1):2467798.

PMID: 40052927 PMC: 11892073. DOI: 10.1080/14756366.2025.2467798.

Single-cell RNA sequencing reveals tumor heterogeneity in small cell neuroendocrine cervical carcinoma.

Xiang X, Tao X, Hua K, Jiang H, Ding J Commun Biol. 2025; 8(1):184.

PMID: 39910262 PMC: 11799506. DOI: 10.1038/s42003-025-07605-y.

The conformation of FOXM1 homodimers in vivo is crucial for regulating transcriptional activities.

Hsu C, Yao X, Chen S, Tsuo T, Wang I Nucleic Acids Res. 2024; 52(22):13625-13643.

PMID: 39535028 PMC: 11662942. DOI: 10.1093/nar/gkae988.

Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients' prognosis.

Wang X, Chen J, Li C, Liu Y, Chen S, Lv F PeerJ. 2024; 12:e17545.

PMID: 38938612 PMC: 11210463. DOI: 10.7717/peerj.17545.

AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.

Nouri M, Varkaris A, Ridinger M, Dalrymple S, Dennehy C, Isaacs J Mol Cancer Ther. 2024; 23(10):1404-1417.

PMID: 38894678 PMC: 11444904. DOI: 10.1158/1535-7163.MCT-23-0933.

References

Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers W . Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol. 2000; 20(23):8969-82. PMC: 86551. DOI: 10.1128/MCB.20.23.8969-8982.2000. View

Korver W, Schilham M, Moerer P, van den Hoff M, Dam K, Lamers W . Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor Trident. Curr Biol. 1998; 8(24):1327-30. DOI: 10.1016/s0960-9822(07)00563-5. View

Chiappa M, Petrella S, Damia G, Broggini M, Guffanti F, Ricci F . Present and Future Perspective on PLK1 Inhibition in Cancer Treatment. Front Oncol. 2022; 12:903016. PMC: 9201472. DOI: 10.3389/fonc.2022.903016. View

Sharma P, Mahen R, Rossmann M, Stokes J, Hardwick B, Huggins D . A cryptic hydrophobic pocket in the polo-box domain of the polo-like kinase PLK1 regulates substrate recognition and mitotic chromosome segregation. Sci Rep. 2019; 9(1):15930. PMC: 6828814. DOI: 10.1038/s41598-019-50702-2. View

Fujiwara Y, Okada K, Omori T, Sugimura K, Miyata H, Ohue M . Multiple therapeutic peptide vaccines for patients with advanced gastric cancer. Int J Oncol. 2017; 50(5):1655-1662. DOI: 10.3892/ijo.2017.3955. View

Shukla S, Bhaskaran N, MacLennan G, Gupta S . Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice. Prostate. 2013; 73(14):1507-17. PMC: 4018753. DOI: 10.1002/pros.22698. View

Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K . Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res. 1999; 59(12):2794-7. View

Kothe M, Kohls D, Low S, Coli R, Cheng A, Jacques S . Structure of the catalytic domain of human polo-like kinase 1. Biochemistry. 2007; 46(20):5960-71. DOI: 10.1021/bi602474j. View

Li L, Gong M, Zhao Y, Zhao X, Li Q . FOXK1 facilitates cell proliferation through regulating the expression of p21, and promotes metastasis in ovarian cancer. Oncotarget. 2017; 8(41):70441-70451. PMC: 5642567. DOI: 10.18632/oncotarget.19713. View

10.

Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y . TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010; 463(7281):676-80. DOI: 10.1038/nature08734. View

11.

Hymel D, Tsuji K, Grant R, Chingle R, Kunciw D, Yaffe M . Design and synthesis of a new orthogonally protected glutamic acid analog and its use in the preparation of high affinity polo-like kinase 1 polo-box domain - binding peptide macrocycles. Org Biomol Chem. 2021; 19(36):7843-7854. PMC: 8456285. DOI: 10.1039/d1ob01120k. View

12.

Chase D, Golden A, Heidecker G, Ferris D . Caenorhabditis elegans contains a third polo-like kinase gene. DNA Seq. 2000; 11(3-4):327-34. DOI: 10.3109/10425170009033251. View

13.

Nakatsumi H, Matsumoto M, Nakayama K . Noncanonical Pathway for Regulation of CCL2 Expression by an mTORC1-FOXK1 Axis Promotes Recruitment of Tumor-Associated Macrophages. Cell Rep. 2017; 21(9):2471-2486. DOI: 10.1016/j.celrep.2017.11.014. View

14.

Chen X, Muller G, Quaas M, Fischer M, Han N, Stutchbury B . The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism. Mol Cell Biol. 2012; 33(2):227-36. PMC: 3554121. DOI: 10.1128/MCB.00881-12. View

15.

Fondevila F, Fernandez-Palanca P, Mendez-Blanco C, Payo-Serafin T, Lozano E, Marin J . Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers (Basel). 2021; 13(21). PMC: 8582569. DOI: 10.3390/cancers13215349. View

16.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

17.

Bowman C, Ayer D, Dynlacht B . Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs. Nat Cell Biol. 2014; 16(12):1202-14. PMC: 4250422. DOI: 10.1038/ncb3062. View

18.

Marceau A, Brison C, Nerli S, Arsenault H, McShan A, Chen E . An order-to-disorder structural switch activates the FoxM1 transcription factor. Elife. 2019; 8. PMC: 6538375. DOI: 10.7554/eLife.46131. View

19.

Zhang X, Tang N, Hadden T, Rishi A . Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 2011; 1813(11):1978-86. DOI: 10.1016/j.bbamcr.2011.03.010. View

20.

Ramkumar P, Lee C, Moradian A, Sweredoski M, Hess S, Sharrocks A . JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1. J Biol Chem. 2015; 290(49):29617-28. PMC: 4705960. DOI: 10.1074/jbc.M115.664649. View